Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
REVENUES        
Government contract revenue $ 413,458 $ 0 $ 443,458 $ 149,625
OPERATING EXPENSES        
Professional fees 609,933 587,192 1,979,848 1,449,218
Payroll and related expenses 406,421 1,161,531 1,609,942 2,426,828
General and administrative 273,510 215,150 998,465 681,678
Total operating expenses 1,289,864 1,963,873 4,588,255 4,557,724
OPERATING LOSS (876,406) (1,963,873) (4,144,797) (4,408,099)
OTHER (INCOME) EXPENSE        
Interest and other debt expenses 126 55,107 54,232 165,317
(Gain) on share for warrant exchanges (55,593) 0 (51,190) 0
Loss on debt extinguishment 0 0 447,011 0
Total other (income) expense (55,467) 55,107 450,053 165,317
NET LOSS (820,939) (2,018,980) (4,594,850) (4,573,416)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (1,358) (5,940) (3,808) (20,803)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (819,581) $ (2,013,040) $ (4,591,042) $ (4,552,613)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.28) $ (1.67) $ (2.52) $ (3.82)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED 2,887,883 1,203,344 1,821,557 1,191,012